Clinical Trials Directory

Trials / Conditions / Metastatic Undifferentiated Pleomorphic Sarcoma

Metastatic Undifferentiated Pleomorphic Sarcoma

8 registered clinical trials studyying Metastatic Undifferentiated Pleomorphic Sarcoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingMeasuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Po
NCT06422806
National Cancer Institute (NCI)Phase 3
RecruitingTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposert
NCT05711615
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advan
NCT05836571
National Cancer Institute LAOPhase 2
TerminatedSintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleo
NCT05017103
M.D. Anderson Cancer CenterPhase 2
TerminatedItacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
NCT03670069
Fred Hutchinson Cancer CenterPhase 1
CompletedRibociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B
NCT03009201
OHSU Knight Cancer InstitutePhase 1
TerminatedSapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
NCT02601209
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Su
NCT02500797
National Cancer Institute (NCI)Phase 2